1-20 of 23
Mark R. Litzow
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

T-cell immune cluster analysis using CyTOF identifies unique subgroups of patients with acute myeloid leukemia.

Clinical Trials & Observations
Talha Badar, Keith Knutson, James M Foran, Naseema Gangat, Kevin D Pavelko, Scott H Kaufmann, Mark R Litzow, Hemant S. Murthy, Davitte Cogen, Margaret Ushman, Arini Arsana, Aref Al-Kali, Hassan B Alkhateeb, Ayalew Tefferi, Mrinal M. Patnaik, Mithun Vinod Shah
Journal: Blood Advances
Blood Adv bloodadvances.2024014553.
https://doi.org/10.1182/bloodadvances.2024014553
Published: 2024
Includes: Supplemental data
Journal Articles

Health-related quality of life with gilteritinib vs placebo posttransplant for FLT3-ITD + acute myeloid leukemia

Clinical Trials & Observations
Betty K. Hamilton, Bhavik J. Pandya, Cristina Ivanescu, Dina Elsouda, Mehdi Hamadani, Yi-Bin Chen, Mark J. Levis, Masumi Ueda Oshima, Mark R. Litzow, Robert J. Soiffer, Celalettin Ustun, Alexander E. Perl, Anurag K. Singh, Nancy Geller, Nahla Hasabou, Matt Rosales, David Cella, Laura Corredoira, Carolina Pestana, Mary M. Horowitz, Brent Logan
Journal: Blood Advances
Blood Adv (2024) 8 (19): 5091–5099.
https://doi.org/10.1182/bloodadvances.2024013746
Published: 2024
Includes: Supplemental data
Journal Articles

Tolerability & long-term disease control by IGHV mutation status among CLL patients on ibrutinib arm of E1912

Clinical Trials & Observations
Tait D. Shanafelt, Xin Victoria Wang, Curtis A. Hanson, Elisabeth Paietta, Susan M. O'Brien, M.D., Jacqueline Claudia Barrientos, Diane F Jelinek, Esteban Braggio, Jose F. Leis, cong zhang, Paul M. Barr, Amanda F Cashen, Anthony R Mato, Avina K Singh, Michael Mullane, Richard F. Little, Harry P. Erba, Richard M. Stone, Mark R Litzow, Martin S. Tallman, Neil E. Kay
Journal: Blood Advances
Blood Adv bloodadvances.2024013474.
https://doi.org/10.1182/bloodadvances.2024013474
Published: 2024
Includes: Supplemental data
Journal Articles

Genetic features and outcomes of allogeneic transplantation in patients with WT1 -mutated myeloid neoplasms

Clinical Trials & Observations
Anmol Baranwal, Rami Basmaci, Rong He, David Viswanatha, Patricia Greipp, Hemant S. Murthy, James Foran, Jeanne Palmer, William J. Hogan, Mark R. Litzow, Mehrdad Hefazi, Abhishek Mangaonkar, Mithun Vinod Shah, Aref Al-Kali, Hassan B. Alkhateeb
Journal: Blood Advances
Blood Adv (2024) 8 (3): 562–570.
https://doi.org/10.1182/bloodadvances.2023010960
Published: 2024
Includes: Supplemental data
Journal Articles

Black African-American patients with primary myelofibrosis: a comparative analysis of phenotype and survival

Naseema Gangat, Andrew Kuykendall, Najla Al Ali, Swati Goel, Maymona Abdelmagid, Aref Al-Kali, Hassan B. Alkhateeb, Kebede H. Begna, Abhishek Mangaonkar, Mark R. Litzow, William Hogan, Mithun Shah, Mrinal M. Patnaik, Animesh Pardanani, Rami Komrokji, Ayalew Tefferi
Journal: Blood Advances
Blood Adv (2023) 7 (12): 2694–2698.
https://doi.org/10.1182/bloodadvances.2022009611
Published: 2023
Journal Articles

Pevonedistat with azacitidine in older patients with TP53 -mutated AML: a phase 2 study with laboratory correlates

Clinical Trials & Observations
Antoine N. Saliba, Scott H. Kaufmann, Eytan M. Stein, Prapti A. Patel, Maria R. Baer, Wendy Stock, Michael Deininger, William Blum, Gary J. Schiller, Rebecca L. Olin, Mark R. Litzow, Tara L. Lin, Brian J. Ball, Michael M. Boyiadzis, Elie Traer, Olatoyosi Odenike, Martha L. Arellano, Alison Walker, Vu H. Duong, Tibor Kovacsovics, Robert H. Collins, Abigail B. Shoben, Nyla A. Heerema, Matthew C. Foster, Kevin L. Peterson, Paula A. Schneider, Molly Martycz, Theophilus J. Gana, Leonard Rosenberg, Sonja Marcus, Ashley O. Yocum, Timothy Chen, Mona Stefanos, Alice S. Mims, Uma Borate, Amy Burd, Brian J. Druker, Ross L. Levine, John C. Byrd, James M. Foran
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2360–2363.
https://doi.org/10.1182/bloodadvances.2022008625
Published: 2023
Includes: Supplemental data
Journal Articles

The impact of early PEG-asparaginase discontinuation in young adults with ALL: a post hoc analysis of the CALGB 10403 study

Clinical Trials & Observations
Ibrahim Aldoss, Jun Yin, Anna Wall, Krzysztof Mrózek, Michaela Liedtke, David F. Claxton, Matthew C. Foster, Frederick R. Appelbaum, Harry P. Erba, Mark R. Litzow, Martin S. Tallman, Richard M. Stone, Richard A. Larson, Anjali S. Advani, Wendy Stock, Selina M. Luger
Journal: Blood Advances
Blood Adv (2023) 7 (2): 196–204.
https://doi.org/10.1182/bloodadvances.2022007791
Published: 2023
Includes: Supplemental data
Journal Articles

Cardiac events in patients with acute myeloid leukemia treated with venetoclax combined with hypomethylating agents

Isla M. Johnson, Evandro D. Bezerra, Faiqa Farrukh, Kristen McCullough, Aref Al-Kali, Hassan B. Alkhateeb, Kebede Begna, Mark R. Litzow, William J. Hogan, Mithun Vinod Shah, Mrinal M. Patnaik, Ayalew Tefferi, Naseema Gangat
Journal: Blood Advances
Blood Adv (2022) 6 (17): 5227–5231.
https://doi.org/10.1182/bloodadvances.2022007333
Published: 2022
Includes: Supplemental data
Journal Articles

Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia

Clinical Trials & Observations
Lori Muffly, Jun Yin, Sawyer Jacobson, Anna Wall, Elisa Quiroz, Anjali S. Advani, Selina M. Luger, Martin S. Tallman, Mark R. Litzow, Matthew C. Foster, Harry P. Erba, Frederick R. Appelbaum, Richard A. Larson, Theresa H.M. Keegan, Wendy Stock
Journal: Blood Advances
Blood Adv (2022) 6 (14): 4085–4092.
https://doi.org/10.1182/bloodadvances.2022007197
Published: 2022
Includes: Supplemental data
Journal Articles

Relationship of iothalamate clearance and NRM in patients receiving fludarabine and melphalan reduced-intensity conditioning

Jade L. Kutzke, Julianna A. Merten, Amanda G. Pawlenty, Erin F. Barreto, Gabe T. Bartoo, Kristin C. Mara, Mark R. Litzow, William J. Hogan, Mithun V. Shah, Abhishek A. Mangaonkar, Nelson Leung, Hassan B. Alkhateeb
Journal: Blood Advances
Blood Adv (2022) 6 (13): 3844–3849.
https://doi.org/10.1182/bloodadvances.2021006395
Published: 2022
Includes: Supplemental data
Journal Articles

Genetic features and clinical outcomes of patients with isolated and comutated DDX41 -mutated myeloid neoplasms

Hassan B. Alkhateeb, Ahmad Nanaa, David Viswanatha, James M. Foran, Talha Badar, Lisa Sproat, Rong He, Phuong Nguyen, Dragan Jevremovic, Mohamad E. Salama, Patricia Greipp, Naseema Gangat, Ayalew Tefferi, Mark R. Litzow, Abhishek A. Mangaonkar, Mithun Vinod Shah, Mrinal Patnaik, Aref Al-Kali
Journal: Blood Advances
Blood Adv (2022) 6 (2): 528–532.
https://doi.org/10.1182/bloodadvances.2021005738
Published: 2022
Includes: Supplemental data
Journal Articles

CNS involvement in AML at diagnosis is rare and does not affect response or survival: data from 11 ECOG-ACRIN trials

Clinical Trials & Observations
Chezi Ganzel, Ju-Whei Lee, Hugo F. Fernandez, Elisabeth M. Paietta, Selina M. Luger, Hillard M. Lazarus, Larry D. Cripe, Dan Douer, Peter H. Wiernik, Jacob M. Rowe, Martin S. Tallman, Mark R. Litzow
Journal: Blood Advances
Blood Adv (2021) 5 (22): 4560–4568.
https://doi.org/10.1182/bloodadvances.2021004999
Published: 2021
Journal Articles

Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)

Se young Han, Krzysztof Mrózek, Jenna Voutsinas, Qian Wu, Elizabeth A. Morgan, Hanne Vestergaard, Robert Ohgami, Philip M. Kluin, Thomas Kielsgaard Kristensen, Sheeja Pullarkat, Michael Boe Møller, Ana-Iris Schiefer, Linda B. Baughn, Young Kim, David Czuchlewski, Jacobien R. Hilberink, Hans-Peter Horny, Tracy I. George, Michelle Dolan, Nam K. Ku, Cecilia Arana Yi, Vinod Pullarkat, Jessica Kohlschmidt, Amandeep Salhotra, Lori Soma, Clara D. Bloomfield, Dong Chen, Wolfgang R. Sperr, Guido Marcucci, Christina Cho, Cem Akin, Jason Gotlib, Sigurd Broesby-Olsen, Melissa Larson, Michael A. Linden, H. Joachim Deeg, Gregor Hoermann, Miguel-Angel Perales, Jason L. Hornick, Mark R. Litzow, Ryotaro Nakamura, Daniel Weisdorf, Gautam Borthakur, Gerwin Huls, Peter Valent, Celalettin Ustun, Cecilia C. S. Yeung
Journal: Blood Advances
Blood Adv (2021) 5 (10): 2481–2489.
https://doi.org/10.1182/bloodadvances.2020003605
Published: 2021
Includes: Supplemental data
Journal Articles

Bone marrow dendritic cell aggregates associate with systemic immune dysregulation in chronic myelomonocytic leukemia

Abhishek A. Mangaonkar, Kaaren K. Reichard, Moritz Binder, Giacomo Coltro, Terra L. Lasho, Ryan M. Carr, April Chiu, Vivian Negron, Mehrdad Hefazi, Theodora Anagnostou, Michael M. Timm, James W. Hiebert, Jose C. Villasboas, Wilson I. Gonsalves, Naseema Gangat, Mithun Shah, Hassan B. Alkhateeb, Aref Al-Kali, Michelle A. Elliott, Kebede H. Begna, Alexandra P. Wolanskyj-Spinner, Mark R. Litzow, William J. Hogan, Stephen M. Ansell, Animesh Pardanani, Ayalew Tefferi, Mrinal M. Patnaik
Journal: Blood Advances
Blood Adv (2020) 4 (21): 5425–5430.
https://doi.org/10.1182/bloodadvances.2020002415
Published: 2020
Includes: Supplemental data
Journal Articles

Real-world outcomes of adult B-cell acute lymphocytic leukemia patients treated with blinatumomab

Clinical Trials & Observations
Talha Badar, Aniko Szabo, Anjali Advani, Martha Wadleigh, Shukaib Arslan, Muhammad Ali Khan, Ibrahim Aldoss, Caitlin Siebenaller, Elizabeth Schultz, Mehrdad Hefazi, Rory M. Shallis, Ilana Yurkiewicz, Nikolai Podoltsev, Anand A. Patel, Emily Curran, Suresh Balasubramanian, Jay Yang, Ryan J. Mattison, Madelyn Burkart, Shira Dinner, Michaela Liedtke, Mark R. Litzow, Ehab Atallah
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2308–2316.
https://doi.org/10.1182/bloodadvances.2019001381
Published: 2020
Includes: Supplemental data
Journal Articles

Survival following allogeneic transplant in patients with myelofibrosis

Clinical Trials & Observations
Krisstina Gowin, Karen Ballen, Kwang Woo Ahn, Zhen-Huan Hu, Haris Ali, Murat O. Arcasoy, Rebecca Devlin, Maria Coakley, Aaron T. Gerds, Michael Green, Vikas Gupta, Gabriela Hobbs, Tania Jain, Malathi Kandarpa, Rami Komrokji, Andrew T. Kuykendall, Kierstin Luber, Lucia Masarova, Laura C. Michaelis, Sarah Patches, Ashley C. Pariser, Raajit Rampal, Brady Stein, Moshe Talpaz, Srdan Verstovsek, Martha Wadleigh, Vaibhav Agrawal, Mahmoud Aljurf, Miguel Angel Diaz, Belinda R. Avalos, Ulrike Bacher, Asad Bashey, Amer M. Beitinjaneh, Jan Cerny, Saurabh Chhabra, Edward Copelan, Corey S. Cutler, Zachariah DeFilipp, Shahinaz M. Gadalla, Siddhartha Ganguly, Michael R. Grunwald, Shahrukh K. Hashmi, Mohamed A. Kharfan-Dabaja, Tamila Kindwall-Keller, Nicolaus Kröger, Hillard M. Lazarus, Jane L. Liesveld, Mark R. Litzow, David I. Marks, Sunita Nathan, Taiga Nishihori, Richard F. Olsson, Attaphol Pawarode, Jacob M. Rowe, Bipin N. Savani, Mary Lynn Savoie, Sachiko Seo, Melhem Solh, Roni Tamari, Leo F. Verdonck, Jean A. Yared, Edwin Alyea, Uday Popat, Ronald Sobecks, Bart L. Scott, Ryotaro Nakamura, Ruben Mesa, Wael Saber
Journal: Blood Advances
Blood Adv (2020) 4 (9): 1965–1973.
https://doi.org/10.1182/bloodadvances.2019001084
Published: 2020
Includes: Supplemental data
Journal Articles

A phase 2 study of ATRA, arsenic trioxide, and gemtuzumab ozogamicin in patients with high-risk APL (SWOG 0535)

Clinical Trials & Observations
Jeffrey E. Lancet, Anna B. Moseley, Steven E. Coutre, Daniel J. DeAngelo, Megan Othus, Martin S. Tallman, Mark R. Litzow, Rami S. Komrokji, Harry P. Erba, Frederick R. Appelbaum
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1683–1689.
https://doi.org/10.1182/bloodadvances.2019001278
Published: 2020
Journal Articles

Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia

Clinical Trials & Observations
Catherine J. Lee, Soyoung Kim, Heather R. Tecca, Stephanie Bo-Subait, Rachel Phelan, Ruta Brazauskas, David Buchbinder, Betty K. Hamilton, Minoo Battiwalla, Navneet S. Majhail, Hillard M. Lazarus, Peter J. Shaw, David I. Marks, Mark R. Litzow, Saurabh Chhabra, Yoshihiro Inamoto, Zachariah DeFilipp, Gerhard C. Hildebrandt, Richard F. Olsson, Kimberly A. Kasow, Jane L. Liesveld, Seth J. Rotz, Sherif M. Badawy, Neel S. Bhatt, Jean A. Yared, Kristin M. Page, Martha L. Arellano, Michael Kent, Nosha Farhadfar, Sachiko Seo, Peiman Hematti, César O. Freytes, Alicia Rovó, Siddhartha Ganguly, Sunita Nathan, Linda Burns, Bronwen E. Shaw, Lori S. Muffly
Journal: Blood Advances
Blood Adv (2020) 4 (6): 983–992.
https://doi.org/10.1182/bloodadvances.2019001126
Published: 2020
Includes: Supplemental data
Journal Articles

Inhibition of the mutated c-KIT kinase in AML1-ETO–positive leukemia cells restores sensitivity to PARP inhibitor

Margaret Nieborowska-Skorska, Elisabeth M. Paietta, Ross L. Levine, Hugo F. Fernandez, Martin S. Tallman, Mark R. Litzow, Tomasz Skorski
Journal: Blood Advances
Blood Adv (2019) 3 (23): 4050–4054.
https://doi.org/10.1182/bloodadvances.2019000756
Published: 2019
Includes: Supplemental data
Journal Articles

Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells

Clinical Trials & Observations
Yi-Bin Chen, Jennifer Le-Rademacher, Ruta Brazauskas, Deidre M. Kiefer, Mehdi Hamadani, John F. DiPersio, Mark R. Litzow, Michael Craig, Mitchell E. Horwitz, Andrew S. Artz, Brian L. McClune, Hugo F. Fernandez, Hien Kim Duong, Hati Kobusingye, Mandi Proue, Rebecca J. Drexler, Mary M. Horowitz, Bronwen E. Shaw, John P. Miller, Sakura Hosoba, Edmund K. Waller, Steven M. Devine
Journal: Blood Advances
Blood Adv (2019) 3 (6): 875–883.
https://doi.org/10.1182/bloodadvances.2018027599
Published: 2019
Includes: Supplemental data